Fabrizio Remotti, MD

Pathology - Anatomic & Clinical, Pathology-Anatomic/Pathology-Clinical
More specialties
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

  • Bone and Joint Infections
  • Bone and Soft Tissue Abnormalities
  • Bone and Soft Tissue Sarcoma
  • Bone and Soft Tissue Tumors
  • Bone Cancer
  • Bone Disease
  • Bone Diseases
  • Immunohistochemistry
  • Soft Tissue Mass
  • Soft Tissue Sarcoma

Academic Appointments

  • Associate Professor of Pathology & Cell Biology at CUMC

Administrative Titles

  • Director, Autopsy and Medical Pathology

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Languages

  • Italian

Gender

  • Male

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Insurance Accepted

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

RiverSpring

  • Special Needs

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Residency: University of Southern California Medical Center
  • Fellowship: Armed Forces Institute

Board Certifications

  • Pathology-Anatomic/Pathology-Clinical

Research

Selected Publications

Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. 2013;32(18):2249-60, 60 e1-21.

Remotti F, Feldman F. Nonneoplastic lesions that simulate primary tumors of bone. Archives of pathology & laboratory medicine. 2012;136(7):772-88.

Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I. PPARgamma agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. The Journal of clinical investigation. 2012;122(3):886-98.

Gonzalez-Lomas G, Cassilly RT, Remotti F, Levine WN. Is the etiology of pretibial cyst formation after absorbable interference screw use related to a foreign body reaction? Clinical orthopaedics and related research. 2011;469(4):1082-8.

Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, Bhat HK. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicology and applied pharmacology. 2010;247(2):83-90.

Singh B, Mense SM, Remotti F, Liu X, Bhat HK. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. Journal of biochemical and molecular toxicology. 2009;23(3):202-11.

Mills J, Matos T, Charytonowicz E, Hricik T, Castillo-Martin M, Remotti F, Lee FY, Matushansky I. Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo. Human cell. 2009;22(4):85-93.

Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis. 2009;30(7):1202-8.

Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, Hei TK, Bhat HK. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicology and applied pharmacology. 2008;232(1):78-85.

Saqi A, Giorgadze TA, Eleazar J, Remotti F, Vazquez MF. Clear cell and eosinophilic oncocytomas of salivary gland: cytological variants or parallels? Diagnostic cytopathology. 2007;35(3):158-63.

Saqi A, Alexis D, Remotti F, Bhagat G. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. American journal of clinical pathology. 2005;123(3):394-404.

Fetsch JF, Laskin WB, Michal M, Remotti F, Heffner D, Ellis G, Furlong M, Miettinen M. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. The American journal of surgical pathology. 2004;28(10):1360-70.

Fetsch JF, Vinh TN, Remotti F, Walker EA, Murphey MD, Sweet DE. Tenosynovial (extraarticular) chondromatosis: an analysis of 37 cases of an underrecognized clinicopathologic entity with a strong predilection for the hands and feet and a high local recurrence rate. The American journal of surgical pathology. 2003;27(9):1260-8.

Remotti F, Fetsch JF, Miettinen M. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues. Human pathology. 2001;32(8):873-9.

Lemos MM, Kindblom LG, Meis-Kindblom JM, Remotti F, Ryd W, Gunterberg B, Willen H. Fine-needle aspiration characteristics of hibernoma. Cancer. 2001;93(3):206-10.

Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122-34.

Cochran AJ, Binder S, Remotti F. The role of microscopic evaluation in the management of cutaneous melanoma. Cancer treatment and research. 1993;65:69-102.